CPSE:NOVO BPharmaceuticals
What Does Novo Nordisk (CPSE:NOVO B) AI Trial Push Mean For Investors?
Novo Nordisk (CPSE:NOVO B) has entered an AI-focused partnership with H1 to support clinical trial operations.
The collaboration uses H1's proprietary AI-ready data and clinical development workflows to support drug development.
The agreement is aimed at improving clinical trial design, execution and site or investigator selection through data driven insights.
This kind of AI partnership in drug development sits within a wider shift toward digital and data infrastructure. It is worth...